SCHEMBL5089141

SCHEMBL5089141

N#Cc1cccc(C(OCc2ccccc2)C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.48
FFAR4 Q5NUL3 1/20 0.47
GPR34 Q9UPC5 1/20 0.46
LMNA P02545 1/20 0.45
FOLH1 Q04609 1/20 0.44
GRM4 Q14833 1/20 0.44
TACR1 P25103 1/20 0.43
MRGPRX1 Q96LB2 1/20 0.43
CNR1 P21554 3/20 0.43
MAOB P27338 1/20 0.42
MRGPRX4 Q96LA9 2/20 0.42
TNF P01375 1/20 0.42
PPIA P62937 1/20 0.42
SLC1A3 P43003 2/20 0.41
SLC1A2 P43004 2/20 0.41
SLC1A1 P43005 2/20 0.41
CNR2 P34972 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5098915 0.99 FFAR1 (0.47) FFAR1FFAR4GPR34LMNAFOLH1
SCHEMBL7527410 0.88 FFAR1 (0.48) FFAR1FFAR4GPR34LMNACNR1
SCHEMBL15610228 0.81 KYNU (0.50) LMNASLC1A3SLC1A2SLC1A1MEN1
SCHEMBL1586340 0.81 SLC1A3 (0.54) LMNASLC1A3SLC1A2SLC1A1MEN1
SCHEMBL11687261 0.81 FFAR1 (0.45) FFAR1FFAR4GPR34LMNATACR1
SCHEMBL9077243 0.79 MEN1 (0.49) LMNATACR1SLC1A3SLC1A2SLC1A1
SCHEMBL2537007 0.79 MAOB (0.46) FFAR1FFAR4MAOBMRGPRX4SLC1A3
SCHEMBL5099707 0.79 GRM4 (0.45) FFAR1FFAR4FOLH1GRM4CNR1
SCHEMBL15610225 0.79 KYNU (0.43) SLC1A3SLC1A2SLC1A1MEN1CYP1A2
SCHEMBL7361912 0.78 FFAR1 (0.53) FFAR1FFAR4GPR34LMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425641-B2 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2008-09-16 US disclosed
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-03-24 US disclosed
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions F12, F11, F2 FFAR1 333/4885FFAR4 1526/4885GPR34 1828/4885
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity SERPINC1, TFPI, F2 FFAR1 1064/4885FFAR4 1530/4885GPR34 3144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.